Laddar...

A Mutation in Human Immunodeficiency Virus Type 1 Protease, N88S, That Causes In Vitro Hypersensitivity to Amprenavir

Amprenavir (Agenerase, 141-W94, VX-478) is a human immunodeficiency virus type 1 (HIV-1) protease inhibitor (PRI) recently approved for the treatment of HIV-1 infection in the United States. A major cause of treatment failure is the development of resistance to PRIs. One potential use for amprenavir...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Ziermann, Rainer, Limoli, Kay, Das, Kalyan, Arnold, Edward, Petropoulos, Christos J., Parkin, Neil T.
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Society for Microbiology 2000
Ämnen:
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC111958/
https://ncbi.nlm.nih.gov/pubmed/10756056
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!